255 results on '"Gillespie, Matthew T"'
Search Results
2. The mouse NKR-P1B:Clr-b recognition system is a negative regulator of innate immune responses
3. Urolithiasis is prevalent and associated with reduced bone mineral density in β‐thalassaemia major
4. Molecular Characterization of the Murine Cytotoxic T-Cell Membrane Glycoprotein Ly-3 (CD8)
5. Oncostatin M promotes bone formation independently of resorption when signaling through leukemia inhibitory factor receptor in mice
6. Osteoclast inhibitory lectin (OCIL) inhibits osteoblast differentiation and function in vitro
7. Interleukin-33, a Target of Parathyroid Hormone and Oncostatin M, Increases Osteoblastic Matrix Mineral Deposition and Inhibits Osteoclast Formation in Vitro
8. The Chemokine Cxcl1 Is a Novel Target Gene of Parathyroid Hormone (PTH)/PTH-Related Protein in Committed Osteoblasts
9. Parathyroid Hormone-Related Protein (PTHrP)
10. Targeting Osteoclasts With Zoledronic Acid Prevents Bone Destruction in Collagen-Induced Arthritis
11. Glycoprotein 130 regulates bone turnover and bone size by distinct downstream signaling pathways
12. Nuclear Transport of Parathyroid Hormone (PTH)-Related Protein Is Dependent on Microtubules
13. Dynamics of Leptomycin B-Sensitive Nucleocytoplasmic Flux of Parathyroid Hormone-Related Protein
14. Fc-OSTEOPROTEGERIN FUSION PROTEIN (Fc-OPG) REDUCES OSTEOCLAST NUMBERS AND PREVENTS BONE DESTRUCTION IN RATS WITH COLLAGEN-INDUCED ARTHRITIS.
15. Bone Morphogenetic Protein 2 Stimulates Osteoclast Differentiation and Survival Supported by Receptor Activator of Nuclear Factor-κB Ligand
16. Of Mice and Men, Recapitulation of Blomstrand’s Chondrodysplasia
17. Osteoprotegerin Produced by Osteoblasts Is an Important Regulator in Osteoclast Development and Function*
18. Nuclear and nucleolar localization of parathyroid hormone-related protein
19. EXPRESSION OF OSTEOCLAST DIFFERENTIATION FACTOR AT SITES OF BONE EROSION IN COLLAGEN-INDUCED ARTHRITIS
20. Breast Cancer Cells Interact with Osteoblasts to Support Osteoclast Formation*
21. Modulation of Osteoclast Differentiation and Function by the New Members of the Tumor Necrosis Factor Receptor and Ligand Families
22. IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis
23. Interleukin 18 Inhibits Osteoclast Formation via T Cell Production of Granulocyte Macrophage Colony-stimulating Factor
24. Interleukin-18 (Interferon-γ-inducing Factor) Is Produced by Osteoblasts and Acts Via Granulocyte/Macrophage Colony-stimulating Factor and Not Via Interferon-γ to Inhibit Osteoclast Formation
25. Receptor activator of nuclear factor κB ligand (RANKL): another link between breast and bone
26. Melphalan modifies the bone microenvironment by enhancing osteoclast formation
27. Bone Disease in Thalassemia: A Molecular and Clinical Overview
28. RARγ is a negative regulator of osteoclastogenesis
29. Genetic Investigation of MHC-Independent Missing-Self Recognition by Mouse NK Cells Using an In Vivo Bone Marrow Transplantation Model
30. Osteoclast formation elicited by interleukin-33 stimulation is dependent upon the type of osteoclast progenitor
31. Oncostatin M promotes bone formation independently of resorption when signaling through leukemia inhibitory factor receptor in mice
32. Molecular Stress-inducing Compounds Increase Osteoclast Formation in a Heat Shock Factor 1 Protein-dependent Manner
33. Thalassemia Bone Disease: A 19-Year Longitudinal Analysis
34. PTHrP Overexpression Increases Sensitivity of Breast Cancer Cells to Apo2L/TRAIL
35. Abstract 2933: HSP90 inhibiting anti-cancer therapeutics enhance bone loss by increasing osteoclast formation: Mechanism of action.
36. HSP90 inhibitors enhance differentiation and MITF (microphthalmia transcription factor) activity in osteoclast progenitors
37. Membrane-bound receptor activator of NFκB ligand (RANKL) activity displayed by osteoblasts is differentially regulated by osteolytic factors
38. Abstract 4886: PTHrP sensitizes breast cancer cells to TRAIL-induced apoptosis
39. Zinc Finger Protein 467 Is a Novel Regulator of Osteoblast and Adipocyte Commitment
40. Germline deletion of AMP‐activated protein kinase β subunits reduces bone mass without altering osteoclast differentiation or function
41. Structural Basis for Antibody Discrimination between Two Hormones That Recognize the Parathyroid Hormone Receptor
42. Crystallization of the receptor-binding domain of parathyroid hormone-related protein in complex with a neutralizing monoclonal antibody Fab fragment
43. Cardiotrophin-1 Is an Osteoclast-Derived Stimulus of Bone Formation Required for Normal Bone Remodeling
44. Osteoclast Inhibitory Lectin, an Immune Cell Product That Is Required for Normal Bone Physiology in Vivo
45. IL-23 Inhibits Osteoclastogenesis Indirectly through Lymphocytes and Is Required for the Maintenance of Bone Mass in Mice
46. EphrinB2 Regulation by PTH and PTHrP Revealed by Molecular Profiling in Differentiating Osteoblasts
47. BMP‐2 regulation of PTHrP and osteoclastogenic factors during osteoblast differentiation of C2C12 cells
48. Impact of cytokines and T lymphocytes upon osteoclast differentiation and function
49. Inflammation-Induced Bone Loss: Can it Be Prevented?
50. Osteoprotegerin Overexpression by Breast Cancer Cells Enhances Orthotopic and Osseous Tumor Growth and Contrasts with That Delivered Therapeutically
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.